Bordetella pertussis toxin (frozen)
Bordetella pertussis toxin (frozen) has been developed in response to the increasing pressure on the IVD industry to supply highly specific, cost-effective antibody capture systems, which are needed for monitoring vaccination programmes. The toxin undergoes two rounds of FHA (Filamentous Haemagglutinin) removal and manufacturing procedures are geared to ensure minimal lot to lot variation. Liquid presentation is the optimal presentation for minimising aggregation, for providing bulk lots to IVD, and for ease of aliquoting, freeze/thawing and storage.
****SHIPPING NOTIFICATION: This product is shipped at ambient temperature. Extensive stability tests have shown no negative effects on antigen performance for 7 days of shipping including several freeze/thaw cycles. Should customers desire shipment on dry ice, this can be performed for an extra fee, please get in contact with us by phone or email.****